An Open-Label Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Corticotropin (Primary)
- Indications IgA nephropathy; Proteinuria
- Focus Therapeutic Use
- 09 Oct 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 09 Oct 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 09 Oct 2017 Status changed from recruiting to active, no longer recruiting.